Second, functional studies using cellular and animal models are crucial to elucidate the precise molecular mechanisms by which UMOD and SIRPA contribute to DKD pathogenesis, which may help identify novel therapeutic targets. This evidence concerns the gene SIRPA and diabetic kidney disease.